Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

ASCO® GI 2025 Summary: mCRC Case-Based Discussion - Lessons Learned

Insights from 2025 ASCO® GI Annual Meeting

R. Mehta, M. Shah

Management of Newly Diagnosed mCRC: Key Trials and Insights

Integrity CE

S. Kopetz

ASCO® GI 2025 Insights: Ph3 BREAKWATER Study - Encorafenib + Cetuxim…

Insights from 2025 ASCO® GI Annual Meeting

S. Kopetz

FDA Approval of Retifanlimab as Frontline Treatment for Advanced SCA…

Northwell Health

N. Hornstein

Treatment Approaches for KRAS-Mutated mCRC

Ibrahim Sahin

Year in Review: CRC & Anal Cancer

OncoAlert

C. Eng

Clinical Advances in KRAS Targeting for Solid Tumors

Horizon CME

D. Hong

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Noteworthy ASCO® 2025 GI Abstracts Including MATTERHORN, ESOPEC, and…

Nicholas Hornstein

U. Grewal, T. Brown

ASCO® GI 2025 Summary: Updates in Anal Cancer

Insights from 2025 ASCO® GI Annual Meeting

C. Eng

Rectal Cancer 101: Diagnosis and Treatment Overview

Nina Niu Sanford

N. Sanford

ASCO® GI 2025 Insights: CheckMate 8HW - First Results of Nivo + Ipi …

Insights from 2025 ASCO® GI Annual Meeting

T. André

Treating GI Cancers With Limited Resources

OncoAlert

N. Rashad

Personalized Treatment in mCRC: Molecular Profiling and Anti-EGFR Th…

14th International Gastrointestinal Cancers Conference (IGICC2024)

P. Philip

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

2025 Updates in mCRC Treatment

Total Health

H. Lenz

ASCO® GI 2025 Insights: Uses of Bevacizumab in Appendiceal Adenocarc…

Insights from 2025 ASCO® GI Annual Meeting

J. Shen